Download PDF
Semin Thromb Hemost 2016; 42(08): 870-876
DOI: 10.1055/s-0036-1592306
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Venous Thromboembolism in Patients Undergoing Craniotomy for Brain Tumors: A U.S. Nationwide Analysis

David J. Cote
1   Department of Neurosurgery, Cushing Neurosurgery Outcomes Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Heloise M. Dubois
1   Department of Neurosurgery, Cushing Neurosurgery Outcomes Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Aditya V. Karhade
1   Department of Neurosurgery, Cushing Neurosurgery Outcomes Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
,
Timothy R. Smith
1   Department of Neurosurgery, Cushing Neurosurgery Outcomes Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
20 October 2016 (online)

    Permissions and Reprints

Abstract

Background Patients who undergo craniotomy for brain tumor have an increased risk of developing venous thromboembolism (VTE). Using the National Surgical Quality Improvement Program (NSQIP) registry, patients undergoing craniotomy for brain tumor from 2006 and 2014 were analyzed to identify risk factors for postoperative VTE.

Methods The study population, identified by Current Procedural Terminology codes, included all NSQIP-reported patients who underwent a craniotomy for brain tumor resection.

Results There were 629 instances of VTE among 19,409 craniotomies for brain tumor (3.2%) recorded in NSQIP. Occurrence of VTE was associated with other postoperative complications on univariate analysis, including pneumonia, respiratory failure, stroke, and sepsis (all p < 0.001). On multivariate analysis, independent predictors of VTE included age 46 to 57 years (odds ratio [OR], 1.432; p = 0.006), 57 to 66 years (OR, 1.550; p = 0.001), or over 66 years (OR, 2.493; p < 0.001), body mass index (BMI) over 32.1 kg/m2 (OR, 1.835; p < 0.001), functional dependence (OR, 1.657; p < 0.001), ventilator dependence (OR, 2.516; p < 0.001), steroid use (OR, 1.661; p < 0.001), prior sepsis (OR, 1.845; p < 0.001), and total operative time 183 to 271 minutes (OR, 1.462; p = 0.032) and longer than 271 minutes (OR, 1.945; p < 0.001).

Conclusions VTE occurs in approximately 3% of patients undergoing craniotomy for brain tumor resection. Independent predictors for developing VTE include older age, higher BMI, recent steroid use, and total operative time.

Keywords

neurosurgery - venous thromboembolismcraniotomy - risk factors - complications - National Surgical Quality Improvement Program
 

  • References

  • 1 Cote DJ, Smith TR. Venous thromboembolism in brain tumor patients. J Clin Neurosci 2016; 25: 13-18
    CrossrefPubMedGoogle Scholar
  • 2 Smith TR, Nanney III AD, Lall RR , et al. Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period. J Clin Neurosci 2015; 22 (3) 519-525
    CrossrefPubMedGoogle Scholar
  • 3 Algattas H, Kimmell KT, Vates GE, Jahromi BS. Analysis of venous thromboembolism risk in patients undergoing craniotomy. World Neurosurg 2015; 84 (5) 1372-1379
    CrossrefPubMedGoogle Scholar
  • 4 Kimmell KT, Jahromi BS. Clinical factors associated with venous thromboembolism risk in patients undergoing craniotomy. J Neurosurg 2015; 122 (5) 1004-1011
    CrossrefPubMedGoogle Scholar
  • 5 Khaldi A, Helo N, Schneck MJ, Origitano TC. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population. J Neurosurg 2011; 114 (1) 40-46
    CrossrefPubMedGoogle Scholar
  • 6 Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest 2002; 122 (6) 1933-1937
    CrossrefPubMedGoogle Scholar
  • 7 Bucci MN, Papadopoulos SM, Chen JC, Campbell JA, Hoff JT. Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial. Surg Neurol 1989; 32 (4) 285-288
    CrossrefPubMedGoogle Scholar
  • 8 Collen JF, Jackson JL, Shorr AF, Moores LK. Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest 2008; 134 (2) 237-249
    CrossrefPubMedGoogle Scholar
  • 9 Browd SR, Ragel BT, Davis GE, Scott AM, Skalabrin EJ, Couldwell WT. Prophylaxis for deep venous thrombosis in neurosurgery: a review of the literature. Neurosurg Focus 2004; 17 (4) E1
    PubMedGoogle Scholar
  • 10 Brose KMJ, Lee AYY. Cancer-associated thrombosis: prevention and treatment. Curr Oncol 2008; 15 (Suppl. 01) S58-S67
    CrossrefPubMedGoogle Scholar
  • 11 Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5 (3) 632-634
    CrossrefPubMedGoogle Scholar
  • 12 Geerts WH, Heit JA, Clagett GP , et al. Prevention of venous thromboembolism. Chest 2001; 119 (1, Suppl): 132S-175S
    CrossrefPubMedGoogle Scholar
  • 13 Hamilton MG, Yee WH, Hull RD, Ghali WA. Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis. Neurosurgery 2011; 68 (3) 571-581
    CrossrefPubMedGoogle Scholar
  • 14 Iorio A, Agnelli G. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis. Arch Intern Med 2000; 160 (15) 2327-2332
    CrossrefPubMedGoogle Scholar
  • 15 Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343 (25) 1846-1850
    CrossrefPubMedGoogle Scholar
  • 16 Carman TL, Kanner AA, Barnett GH, Deitcher SR. Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J 2003; 96 (1) 17-22
    CrossrefPubMedGoogle Scholar
  • 17 Rolston JD, Han SJ, Bloch O, Parsa AT. What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients?. J Neurosurg 2014; 121 (4) 908-918
    CrossrefPubMedGoogle Scholar
  • 18 Molena D, Mungo B, Stem M, Feinberg RL, Lidor AO. Prevalence, impact, and risk factors for hospital-acquired conditions after major surgical resection for cancer: a NSQIP analysis. J Gastrointest Surg 2015; 19 (1) 142-151 , discussion 151
    CrossrefPubMedGoogle Scholar
  • 19 Kantar RS, Haddad AG, Tamim H, Jamali F, Taher AT. Venous thromboembolism and preoperative steroid use: analysis of the NSQIP database to evaluate risk in surgical patients. Eur J Intern Med 2015; 26 (7) 528-533
    CrossrefPubMedGoogle Scholar
  • 20 Cohen AT, Tapson VF, Bergmann JF , et al; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371 (9610) 387-394
    CrossrefPubMedGoogle Scholar
  • 21 Kurtoglu M, Yanar H, Bilsel Y , et al. Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin. World J Surg 2004; 28 (8) 807-811
    CrossrefPubMedGoogle Scholar
  • 22 Scales DC, Riva-Cambrin J, Le TL, Pinto R, Cook DJ, Granton JT ; Canadian Critical Care Trials Group. Prophylaxis against venous thromboembolism in neurointensive care patients: survey of Canadian practice. J Crit Care 2009; 24 (2) 176-184
    CrossrefPubMedGoogle Scholar
  • 23 Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 1998; 43 (5) 1074-1081
    CrossrefPubMedGoogle Scholar
  • 24 Gerlach R, Raabe A, Beck J, Woszczyk A, Seifert V. Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery. Eur Spine J 2004; 13 (1) 9-13
    CrossrefPubMedGoogle Scholar
  • 25 Velmahos GC, Nigro J, Tatevossian R , et al. Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: are current methods of DVT prophylaxis insufficient?. J Am Coll Surg 1998; 187 (5) 529-533
    CrossrefPubMedGoogle Scholar
  • 26 Zareba P, Wu C, Agzarian J, Rodriguez D, Kearon C. Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery. Br J Surg 2014; 101 (9) 1053-1062
    CrossrefPubMedGoogle Scholar
  • 27 Smith TR, Rambachan A, Cote D, Cybulski G, Laws ER. Market-based health care in specialty surgery: finding patient-centered shared value. Neurosurgery 2015; 77 (4) 509-516 , discussion 516
    CrossrefPubMedGoogle Scholar
  • 28 Aher CV, Kubasiak JC, Daly SC , et al. The utilization of laparoscopy in ventral hernia repair: an update of outcomes analysis using ACS-NSQIP data. Surg Endosc 2015; 29 (5) 1099-1104
    CrossrefPubMedGoogle Scholar
  • 29 Seicean A, Seicean S, Schiltz NK , et al. Short-term outcomes of craniotomy for malignant brain tumors in the elderly. Cancer 2013; 119 (5) 1058-1064
    CrossrefPubMedGoogle Scholar
  • 30 Qian C, Yan H, Hu X, Zhang W, Liu H. Increased risk of venous thromboembolism in patients with brain tumors: a systematic review and meta-analysis. Thromb Res 2016; 137: 58-63
    CrossrefPubMedGoogle Scholar
  • 31 Brandes AA, Scelzi E, Salmistraro G , et al. Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer 1997; 33 (10) 1592-1596
    CrossrefPubMedGoogle Scholar
  • 32 Walsh DC, Kakkar AK. Thromboembolism in brain tumors. Curr Opin Pulm Med 2001; 7 (5) 326-331
    CrossrefPubMedGoogle Scholar
  • 33 Rodas RA, Fenstermaker RA, McKeever PE , et al. Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report. J Neurosurg 1998; 89 (2) 200-205
    CrossrefPubMedGoogle Scholar
  • 34 Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer 2000; 89 (3) 640-646
    CrossrefPubMedGoogle Scholar
  • 35 Smith SF, Simpson JM, Sekhon LH. Prophylaxis for deep venous thrombosis in neurosurgical oncology: review of 2779 admissions over a 9-year period. Neurosurg Focus 2004; 17 (4) E4
    PubMedGoogle Scholar
  • 36 Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004; 100 (8) 1717-1723
    CrossrefPubMedGoogle Scholar
  • 37 Chiocca EA, Schwartzbaum JA. Gliomas and venous thromboembolism: how common?. J Neurosurg 2007; 106 (4) 599-600 , discussion 600
    CrossrefPubMedGoogle Scholar
  • 38 Semrad TJ, O'Donnell R, Wun T , et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 2007; 106 (4) 601-608
    CrossrefPubMedGoogle Scholar
  • 39 Ghanim AJ, Daskalakis C, Eschelman DJ, Kraft WK. A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants. J Thromb Thrombolysis 2007; 24 (3) 247-254
    CrossrefPubMedGoogle Scholar
  • 40 Jenkins EO, Schiff D, Mackman N, Key NS. Venous thromboembolism in malignant gliomas. J Thromb Haemost 2010; 8 (2) 221-227
    PubMedGoogle Scholar
  • 41 Lima J. Venous thromboembolism and gliomas: the need for increased vigilance. Clin J Oncol Nurs 2011; 15 (6) 687-690
    CrossrefPubMedGoogle Scholar
  • 42 Smith TR, Lall RR, Graham RB , et al. Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period. J Neurooncol 2014; 120 (2) 347-352
    CrossrefPubMedGoogle Scholar
  • 43 Cote DJ, Smith TR. Venous thromboembolism in brain tumor patients. J Clin Neurosci 2016; 25: 13-18
    CrossrefPubMedGoogle Scholar
  • 44 Danish SF, Burnett MG, Ong JG, Sonnad SS, Maloney-Wilensky E, Stein SC. Prophylaxis for deep venous thrombosis in craniotomy patients: a decision analysis. Neurosurgery 2005; 56 (6) 1286-1292 , discussion 1292–1294
    CrossrefPubMedGoogle Scholar
  • 45 Deep K, Jigajinni MV, Fraser MH, McLean AN. Prophylaxis of thromboembolism in spinal injuries—survey of practice in spinal units in the British Isles. Injury 2002; 33 (4) 353-355
    CrossrefPubMedGoogle Scholar
  • 46 Simanek R, Vormittag R, Hassler M , et al. Venous thromboembolism and survival in patients with high-grade glioma. Neuro-oncol 2007; 9 (2) 89-95
    PubMedGoogle Scholar
  • 47 Chaichana KL, Pendleton C, Jackson C , et al. Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors. Neurol Res 2013; 35 (2) 206-211
    CrossrefPubMedGoogle Scholar
  • 48 Swann KW, Black PM. Deep vein thrombosis and pulmonary emboli in neurosurgical patients: a review. J Neurosurg 1984; 61 (6) 1055-1062
    CrossrefPubMedGoogle Scholar
  • 49 Nurmohamed MT, van Riel AM, Henkens CM , et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 1996; 75 (2) 233-238
    PubMedGoogle Scholar
  • 50 Skillman JJ, Collins RE, Coe NP , et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery 1978; 83 (3) 354-358
    PubMedGoogle Scholar
  • 51 Macdonald RL, Amidei C, Baron J , et al. Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol 2003; 59 (5) 363-372
    PubMedGoogle Scholar
  • 52 Geerts WH, Jay RM, Code KI , et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335 (10) 701-707
    CrossrefPubMedGoogle Scholar
  • 53 Simonneau G, Sors H, Charbonnier B , et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 1997; 337 (10) 663-669
    CrossrefPubMedGoogle Scholar
  • 54 Kim J, Gearhart MMP, Zurick A, Zuccarello M, James L, Luchette FA. Preliminary report on the safety of heparin for deep venous thrombosis prophylaxis after severe head injury. J Trauma 2002; 53 (1) 38-42 , discussion 43
    CrossrefPubMedGoogle Scholar
  • 55 Clagett GP, Anderson Jr FA, Geerts W , et al. Prevention of venous thromboembolism. Chest 1998; 114 (5, Suppl): 531S-560S
    CrossrefPubMedGoogle Scholar
  • 56 Raj D, Marshall RW. Prophylaxis against thromboembolism in spinal surgery. Arch Orthop Trauma Surg 2008; 128 (12) 1365-1371
    CrossrefPubMedGoogle Scholar
  • 57 Norwood SH, Berne JD, Rowe SA, Villarreal DH, Ledlie JT. Early venous thromboembolism prophylaxis with enoxaparin in patients with blunt traumatic brain injury. J Trauma 2008; 65 (5) 1021-1026 , discussion 1026–1027
    CrossrefPubMedGoogle Scholar
  • 58 Salmaggi A, Simonetti G, Trevisan E , et al. Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review. J Neurooncol 2013; 113 (2) 293-303
    CrossrefPubMedGoogle Scholar